Toggle navigation
Home
Search
Services
Blog
Contact
About
Oral Antisense Therapy for Cancer
Manoharan, Muthiah
Isis Pharmaceuticals, Inc., Carlsbad, CA, United States
Search 8 grants from Muthiah Manoharan
Search grants from Isis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
CT fluoroscopy guided robotically assisted lung biopsy
Heat Shock and Steroid Receptor Signaling
Area Health Education Center Cooperative Agreement
Home Health Maintenance Patterns in the Elderly
Symposium on Information-theoretic Approaches to Linguistics
Recently added grants:
Glutamatergic basal forebrain neurons in aversion-resistant drinking
Unraveling strain-level variation in the induction of anti-inflammatory responses in the intestine
Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery
Pathogenesis of Primary Biliary Cholangitis
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA083543-01
Application #
6020093
Study Section
Special Emphasis Panel (ZRG1-SSS-1 (02))
Program Officer
Fu, Yali
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$123,990
Indirect Cost
Institution
Name
Isis Pharmaceuticals, Inc.
Department
Type
DUNS #
361949092
City
Carlsbad
State
CA
Country
United States
Zip Code
92010
Comments
Be the first to comment on Muthiah Manoharan's grant